ArticleFrontiers in medicine2025
Hysteroscopic sutureless fixation of the levonorgestrel-releasing intrauterine system in the treatment of heavy menstrual bleeding.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- GyneFix levonorgestrel-releasing intrauterine system for Chinese patients: a preliminary retrospective self-controlled observational study.BMC women's health · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study investigated the safety and efficacy of hysteroscopic sutureless fixation of the levonorgestrel-releasing intrauterine system (LNG-IUS) for treating heavy menstrual bleeding (HMB), providing a viable therapeutic option for patients at high risk of LNG-IUS expulsion. Methods: Ninety patients were enrolled and equally divided into three groups: conventional implantation of LNG-IUS group (control group), hysteroscopic suture fixation of LNG-IUS group (suture fixation group) and hysteroscopic sutureless fixation of LNG-IUS group (sutureless fixation group). The rates of LNG-IUS expulsion and displacement, complication rates, pre- and postoperative menstrual flow, pain scores, and life satisfaction scores were recorded for each of the three groups. Results: The LNG-IUS expulsion rate in the sutureless fixation group was 3.3% and the displacement rate was 10%. There was no significant difference compared to the suture fixation group (3.3% LNG-IUS expulsion rate and 16.7% displacement rate in the suture fixation group, Conclusion: Our findings indicate that hysteroscopic sutureless fixation of the LNG-IUS is a safe, effective, and minimally invasive surgical procedure to prevent the LNG-IUS expulsion. This procedure leads to a significant reduction in menstrual flow, relieves the symptoms of dysmenorrhea, and improves patient quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.